Drug intelligence / Profile preview

Yi'ai Fuzheng No.II Decoction

Development stage
Unknown
Lead developer
Zhongnan Hospital of Wuhan University
Administration
Oral
01

Overview

Yi'ai Fuzheng No.II Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by Zhongnan Hospital of Wuhan University. It is primarily investigated as an adjuvant therapy for patients with advanced triple-negative breast cancer (TNBC) who are undergoing conventional treatments such as radiotherapy and chemotherapy. The decoction is designed based on the TCM principle of "Fuzheng," which aims to strengthen the body's vital energy and immune function to improve tolerance to aggressive anti-cancer therapies. Clinical studies, such as ChiCTR2300073932, evaluate its efficacy in improving tumor response rates, disease control, and survival outcomes, while also assessing its ability to mitigate treatment-related toxicities and improve the quality of life as measured by TCM syndrome scores and performance status.

Other names
Yi'ai Fuzheng No.II DecoctionYi'ai Fuzheng No.2 DecoctionYi'ai Fuzheng Formula II

Beyond the preview

Go deeper on Yi'ai Fuzheng No.II Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yi'ai Fuzheng No.II Decoction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call